Eli Lilly’s weight loss pill clears latest trial - Semafor
Semaforarrow_outwardEli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds
ABC Newsarrow_outwardCiti's Geoff Meacham on Eli Lilly's stock climbing as weight loss pill clears latest trial
CNBCarrow_outwardLilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
Eli Lilly and Companyarrow_outwardEli Lilly Stock Rises on Latest Weight-Loss Pill Data - Barron's
Barron'sarrow_outwardStocks to Watch Today : AMD, Eli Lilly, EchoStar, Trump Media, NovaBay Pharma, MongoDB - Eurasia Business News
Eurasia Business Newsarrow_outwardWeight loss pill seeks approval - ABC Columbia
ABC Columbiaarrow_outwardWhy Eli Lilly Stock Trounced the Market on Tuesday - Mitrade
Mitradearrow_outwardS&P 500 Gains and Losses Today: Eli Lilly Stock Soars as Weight-Loss Pill Shows Promise; Beverage Makers Face Pressure - Investopedia
Investopediaarrow_outwardVa. backs big pharma deals for AstraZeneca in Albemarle, Eli Lilly in Goochland - Richmond Times-Dispatch
Richmond Times-Dispatcharrow_outwardFed Shake-Up, Market Calm, And Eli Lilly’s Weight-Loss Win - Finimize
Finimizearrow_outwardIndiana-based Eli Lilly seeks regulatory approval for weight loss pill - WDRB
WDRBarrow_outwardLilly Scores Another Obesity Win; Novo Stock Slumps - Investor's Business Daily
Investor's Business Dailyarrow_outwardWhy Eli Lilly is bullish on its oral GLP-1 after Phase 3 success - Medical Marketing and Media
Medical Marketing and Mediaarrow_outwardEli Lilly’s Oral GLP-1 Orforglipron Successful in Third Phase 3 Trial - HIT Consultant
HIT Consultantarrow_outwardEli Lilly Stock Surges on Promising Trial Results - TipRanks
TipRanksarrow_outwardOrforglipron Phase-3 Success Prompts Submissions for Obesity - Medscape
Medscapearrow_outwardEli Lilly: Strong Orforglipron Data in Second Obesity Trial Support On-Schedule Regulatory Filings - Morningstar
Morningstararrow_outwardEli Lilly's Orforglipron: A Game-Changer in Oral GLP-1 Therapy and a Must-Hold Play for 2026 Growth - AInvest
AInvestarrow_outwardEli Lilly's weight loss pill will likely be the market-leading product, says BofA's Tim Anderson - MSN
MSNarrow_outwardPhysician Views Preview: Dermatologists to dish on uptake of Eli Lilly's Ebglyss - FirstWord Pharma
FirstWord Pharmaarrow_outwardTD Cowen reiterates Buy rating on Eli Lilly stock after Phase III data - Investing.com
Investing.comarrow_outwardEli Lilly to Seek Approval for Obesity Pill Orforglipron After Trial Shows Weight Loss in Diabetic Patients - geneonline.com
Geneonline.comarrow_outwardEli Lilly (LLY) Advances Obesity Drug Orforglipron With Positive Phase 3 Results - simplywall.st
Simplywall.starrow_outwardEli Lilly Stock Jumps On Weight-Loss Pill Trial - Benzinga
Benzingaarrow_outwardNasdaq 100 and S&P500: Fed Shake-Up Hits Real Estate Sector, Eli Lilly Surges, Nvidia Next Up - FXEmpire
FXEmpirearrow_outwardLilly to submit obesity pill after hitting goal in third late-stage trial - BioPharma Dive
BioPharma Divearrow_outwardEli Lilly’s obesity pill is ready to ask for global approval - Quartz
Quartzarrow_outwardTop Stock Movers Now: Eli Lilly, EchoStar, Constellation Brands, and More - Yahoo Finance
Yahoo Financearrow_outwardOral GLP-1 weight loss drug proves successful in latest human trial - Straight Arrow News
Straight Arrow Newsarrow_outwardEli Lilly could bring first widely available GLP‑1 pill for obesity, diabetes to market this year - Scripps News
Scripps Newsarrow_outwardLilly pill cuts body weight by 10.5% in patients with type 2 diabetes - Reuters
Reutersarrow_outwardEli Lilly Stock Climbs on Weight-Loss Drug Trial Results - Schaeffer's Investment Research
Schaeffer's Investment Researcharrow_outwardStock Movers: AT&T, Eli Lilly, AMD - Bloomberg
Bloombergarrow_outwardEli Lilly GLP-1 pill shows promising weight loss in type 2 diabetes trial - USA Today
USA Todayarrow_outwardHow the top pharma companies are doing as Eli Lilly is S&P 500’s biggest gainer - Seeking Alpha
Seeking Alphaarrow_outwardEli Lilly Orforglipron Results: Weight-Loss Pill for Obesity & Diabetes - News and Statistics - IndexBox
IndexBoxarrow_outwardEli Lilly advances game changing pill for obesity treatment - Rolling Out
Rolling Outarrow_outwardEli Lilly on track to apply for FDA approval of weight loss pill this year - medwatch.com
Medwatch.comarrow_outwardLilly obesity-pill trial results find a warmer reception on Wall Street this time around - MarketWatch
MarketWatcharrow_outwardLilly Plots Path to FDA After Second Phase III Readout for Orforglipron - BioSpace
BioSpacearrow_outwardEli Lilly’s once-daily weight loss pill succeeds in latest trial, paving the way for global approval - Yahoo News Canada
Yahoo News Canadaarrow_outwardAnne White to retire as head of Lilly Neuroscience after three decades at company - PharmaTimes
PharmaTimesarrow_outwardWolfspeed, Eli Lilly, EchoStar - TradingView
TradingViewarrow_outwardEli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals - The Wall Street Journal
The Wall Street Journalarrow_outwardEli Lilly’s Oral Drug Delivers Significant Weight Loss In Late-Stage Study - Stocktwits
Stocktwitsarrow_outwardEli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial - statnews.com
Statnews.comarrow_outwardLilly rounds out oral GLP-1 approval bid with phase 3 obesity win for patients with diabetes - Fierce Biotech
Fierce Biotecharrow_outwardNew GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval - CNN
CNNarrow_outwardEli Lilly advances weight loss pill towards regulatory submissions after successful trial - Proactive financial news
Proactive financial newsarrow_outwardStudents invited to forge STEM careers at Purdue’s 10th annual Lilly Day - Purdue University
Purdue Universityarrow_outwardEli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried? - The Motley Fool
The Motley Foolarrow_outwardEli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands - The Guardian
The Guardianarrow_outwardEli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down - Forbes
Forbesarrow_outwardPill Causes Major Weight Loss in Eli Lilly Trial’s Results - The New York Times
The New York Timesarrow_outwardLilly confirms plan to sell New Jersey plant amid larger US production ramp-up - Fierce Pharma
Fierce Pharmaarrow_outward
Eli Lilly close
- 2025-08-27 06:20 event
- 56 sourceslanguage
- 2000+ ads_click
- 5 days ago schedule